BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 23224615)

  • 1. Genetic association of IFN-γ +874T/A polymorphism in Mexican patients with drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Charli-Joseph Y; Lima G; Ramos-Bello D; Aguilar D; Orozco-Topete R; Llorente L
    Arch Dermatol Res; 2013 May; 305(4):353-7. PubMed ID: 23224615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of combined IL-13/IL-4R signaling pathway gene polymorphism with Stevens-Johnson syndrome accompanied by ocular surface complications.
    Ueta M; Sotozono C; Inatomi T; Kojima K; Hamuro J; Kinoshita S
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):1809-13. PubMed ID: 18263811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population.
    Tassaneeyakul W; Jantararoungtong T; Chen P; Lin PY; Tiamkao S; Khunarkornsiri U; Chucherd P; Konyoung P; Vannaprasaht S; Choonhakarn C; Pisuttimarn P; Sangviroon A; Tassaneeyakul W
    Pharmacogenet Genomics; 2009 Sep; 19(9):704-9. PubMed ID: 19696695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of HLA class I and class II 4-digit allele level in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Cristallo AF; Schroeder J; Citterio A; Santori G; Ferrioli GM; Rossi U; Bertani G; Cassano S; Gottardi P; Ceschini N; Barocci F; Ribizzi G; Cutrupi V; Cairoli R; Rapisarda V; Pastorello EA; Barocci S
    Int J Immunogenet; 2011 Aug; 38(4):303-9. PubMed ID: 21545408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in the genetics and immunology of Stevens-Johnson syndrome and toxic epidermal necrosis.
    Chung WH; Hung SI
    J Dermatol Sci; 2012 Jun; 66(3):190-6. PubMed ID: 22541332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-B*1502 strongly predicts carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain.
    Kulkantrakorn K; Tassaneeyakul W; Tiamkao S; Jantararoungtong T; Prabmechai N; Vannaprasaht S; Chumworathayi P; Chen P; Sritipsukho P
    Pain Pract; 2012 Mar; 12(3):202-8. PubMed ID: 21676164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Fas Ligand gene polymorphism with Stevens-Johnson syndrome.
    Ueta M; Sotozono C; Inatomi T; Kojima K; Hamuro J; Kinoshita S
    Br J Ophthalmol; 2008 Jul; 92(7):989-91. PubMed ID: 18577653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Caproni M; Torchia D; Schincaglia E; Volpi W; Frezzolini A; Schena D; Marzano A; Quaglino P; De Simone C; Parodi A; Barletta E; Fabbri P
    Br J Dermatol; 2006 Oct; 155(4):722-8. PubMed ID: 16965421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic markers and danger signals in stevens-johnson syndrome and toxic epidermal necrolysis.
    Chung WH; Hung SI
    Allergol Int; 2010 Dec; 59(4):325-32. PubMed ID: 20962567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome.
    Ko TM; Chung WH; Wei CY; Shih HY; Chen JK; Lin CH; Chen YT; Hung SI
    J Allergy Clin Immunol; 2011 Dec; 128(6):1266-1276.e11. PubMed ID: 21924464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific association of the rs6500265 and rs9933632 single-nucleotide polymorphisms in Japanese patients with antipyretic analgesic-related Stevens-Johnson syndrome and toxic epidermal necrolysis with severe ocular involvements.
    Okamoto-Uchida Y; Nakamura R; Matsunaga K; Aihara M; Saito Y
    Pharmacogenet Genomics; 2018 Mar; 28(3):95-98. PubMed ID: 29239905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of TNF-alpha, TGF-beta 1, IL-10, IL-6, IFN-gamma, MBL, GPIA, and IL1A gene polymorphisms in patients with idiopathic thrombocytopenic purpura.
    Pehlivan M; Okan V; Sever T; Balci SO; Yilmaz M; Babacan T; Pehlıvan S
    Platelets; 2011; 22(8):588-95. PubMed ID: 21591983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide association study of serious blistering skin rash caused by drugs.
    Shen Y; Nicoletti P; Floratos A; Pirmohamed M; Molokhia M; Geppetti P; Benemei S; Giomi B; Schena D; Vultaggio A; Stern R; Daly MJ; John S; Nelson MR; Pe'er I;
    Pharmacogenomics J; 2012 Apr; 12(2):96-104. PubMed ID: 21221126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stevens-Johnson syndrome and toxic epidermal necrolysis--updates and innovations].
    Halevy S
    Harefuah; 2010 Mar; 149(3):186-90, 193. PubMed ID: 20684173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor 3 gene polymorphisms in Japanese patients with Stevens-Johnson syndrome.
    Ueta M; Sotozono C; Inatomi T; Kojima K; Tashiro K; Hamuro J; Kinoshita S
    Br J Ophthalmol; 2007 Jul; 91(7):962-5. PubMed ID: 17314152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular surface inflammation mediated by innate immunity.
    Ueta M; Kinoshita S
    Eye Contact Lens; 2010 Sep; 36(5):269-81. PubMed ID: 20703156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetics of toxic epidermal necrolysis.
    Lee MT; Hung SI; Wei CY; Chen YT
    Expert Opin Pharmacother; 2010 Sep; 11(13):2153-62. PubMed ID: 20536296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor 9 polymorphism in patients with erythema multiforme, Stevens Johnson syndrome and Stevens Johnson syndrome/toxic epidermal necrolysis overlap syndrome.
    Turan H; Bulbul Baskan E; Yakut T; Karkucak M; Tunali S; Saricaoglu H
    Bratisl Lek Listy; 2011; 112(5):260-3. PubMed ID: 21682079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations.
    Teraki Y; Shibuya M; Izaki S
    Clin Exp Dermatol; 2010 Oct; 35(7):723-8. PubMed ID: 19874350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased soluble Fas ligand levels in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis preceding skin detachment.
    Murata J; Abe R; Shimizu H
    J Allergy Clin Immunol; 2008 Nov; 122(5):992-1000. PubMed ID: 18692887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.